Suppr超能文献

洛美沙星的作用机制。

Mechanism of action of lomefloxacin.

作者信息

Piddock L J, Hall M C, Wise R

机构信息

Department of Medical Microbiology, University of Birmingham Medical School, United Kingdom.

出版信息

Antimicrob Agents Chemother. 1990 Jun;34(6):1088-93. doi: 10.1128/AAC.34.6.1088.

Abstract

The inhibition of supercoiling activity of reconstituted Escherichia coli DNA gyrase by lomefloxacin, ciprofloxacin, and norfloxacin was determined. The concentrations of quinolones needed to inhibit DNA synthesis in Escherichia coli, Enterobacter cloacae, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were also measured. The kinetics of uptake of [14C]lomefloxacin and unlabeled lomefloxacin into whole cells of E. coli KL-16 and S. aureus NCTC 8532 and the induction of RecA in E. coli GC2241 were assayed. All strains had wild-type susceptibilities to quinolones. The concentration of quinolones needed to inhibit DNA synthesis by 50% correlated with the MIC for members of the family Enterobacteriaceae and P. aeruginosa. The concentration of quinolones needed to inhibit DNA synthesis by 50% for late-logarithmic-phase S. aureus also correlated with the MIC, unlike the data from early-logarithmic-phase cultures. E. coli and S. aureus showed a similar pattern of uptake kinetics of [14C]lomefloxacin and unlabeled lomefloxacin, indicating that the difference in the susceptibilities of the two species is probably due to different target site affinities. Essentially, lomefloxacin was less active than ciprofloxacin and ofloxacin and had activity similar to those of norfloxacin and enoxacin.

摘要

测定了洛美沙星、环丙沙星和诺氟沙星对重组大肠杆菌DNA回旋酶超螺旋活性的抑制作用。还测定了喹诺酮类药物抑制大肠杆菌、阴沟肠杆菌、粘质沙雷氏菌、肺炎克雷伯菌、铜绿假单胞菌和金黄色葡萄球菌中DNA合成所需的浓度。检测了[14C]洛美沙星和未标记的洛美沙星进入大肠杆菌KL-16和金黄色葡萄球菌NCTC 8532全细胞的摄取动力学以及大肠杆菌GC2241中RecA的诱导情况。所有菌株对喹诺酮类药物均具有野生型敏感性。抑制DNA合成50%所需的喹诺酮类药物浓度与肠杆菌科成员和铜绿假单胞菌的最低抑菌浓度(MIC)相关。与对数早期培养的数据不同,对数后期金黄色葡萄球菌抑制DNA合成50%所需的喹诺酮类药物浓度也与MIC相关。大肠杆菌和金黄色葡萄球菌对[14C]洛美沙星和未标记的洛美沙星表现出相似的摄取动力学模式,表明这两个物种敏感性的差异可能是由于靶位点亲和力不同。从本质上讲,洛美沙星的活性低于环丙沙星和氧氟沙星,其活性与诺氟沙星和依诺沙星相似。

相似文献

1
Mechanism of action of lomefloxacin.洛美沙星的作用机制。
Antimicrob Agents Chemother. 1990 Jun;34(6):1088-93. doi: 10.1128/AAC.34.6.1088.
4
Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):29S-34S. doi: 10.1016/0732-8893(89)90062-x.
5
In vitro activity of lomefloxacin (NY-198 or SC 47111).洛美沙星(NY - 198或SC 47111)的体外活性。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):97S-101S. doi: 10.1016/0732-8893(89)90075-8.
7
In vitro antibacterial activity of Q-35, a new fluoroquinolone.新型氟喹诺酮类药物Q-35的体外抗菌活性
Antimicrob Agents Chemother. 1992 Aug;36(8):1708-14. doi: 10.1128/AAC.36.8.1708.
8
Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.二氟喹诺酮类药物洛美沙星的体外活性比较
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):65S-76S. doi: 10.1016/0732-8893(89)90069-2.

引用本文的文献

4
Lomefloxacin clinical pharmacokinetics.洛美沙星的临床药代动力学。
Clin Pharmacokinet. 1993 Jul;25(1):6-19. doi: 10.2165/00003088-199325010-00002.
5
New quinolones and gram-positive bacteria.新型喹诺酮类药物与革兰氏阳性菌
Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163.
9
Mode of action of the new quinolones: new data.新型喹诺酮类药物的作用机制:新数据
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):223-31. doi: 10.1007/BF01966994.

本文引用的文献

3
Genetic control of DNA initiation in Escherichia coli.大肠杆菌中DNA起始的遗传控制。
J Mol Biol. 1973 Feb 25;74(2):205-21. doi: 10.1016/0022-2836(73)90107-1.
9
Fluorometric assay for fleroxacin uptake by bacterial cells.细菌细胞摄取氟罗沙星的荧光测定法。
Antimicrob Agents Chemother. 1989 Jan;33(1):27-9. doi: 10.1128/AAC.33.1.27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验